FAFGX | UIVCX | FAFGX / UIVCX | |
Total Expense Ratio | 0.40 | 1.69 | 24% |
Annual Report Gross Expense Ratio | 0.40 | 7.21 | 6% |
Fund Existence | 5 years | 3 years | - |
Gain YTD | 3.351 | 3.229 | 104% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 303B | 4.32M | 7,013,889% |
Annual Yield % from dividends | 0.61 | 0.00 | - |
Returns for 1 year | 7.60 | 2.02 | 377% |
Returns for 3 years | 44.86 | 40.95 | 110% |
Returns for 5 years | N/A | N/A | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NUGCX | 35.37 | 0.02 | +0.06% |
Nuveen Global Dividend Growth C | |||
PSGIX | 20.60 | N/A | N/A |
BlackRock Advantage Small Cap Gr Instl | |||
BRGAX | 37.96 | N/A | N/A |
iShares Russell 1000 Large-Cap Idx Inv A | |||
SHSKX | 65.94 | N/A | N/A |
BlackRock Health Sciences Opps K | |||
NWAUX | 14.61 | -0.02 | -0.14% |
Nationwide GQG US Quality Eq A |